Marrone Bio Innovations (MBII) vs. Ciner Resources (CINR) Financial Contrast
Marrone Bio Innovations (NASDAQ: MBII) and Ciner Resources (NYSE:CINR) are both small-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.
Risk & Volatility
Marrone Bio Innovations has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, Ciner Resources has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500.
Valuation and Earnings
This table compares Marrone Bio Innovations and Ciner Resources’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Marrone Bio Innovations||$15.53 million||2.24||-$19.96 million||N/A||N/A|
|Ciner Resources||$490.40 million||0.98||$115.10 million||$1.99||12.02|
Ciner Resources has higher revenue and earnings than Marrone Bio Innovations.
Institutional & Insider Ownership
29.5% of Marrone Bio Innovations shares are held by institutional investors. Comparatively, 9.0% of Ciner Resources shares are held by institutional investors. 7.3% of Marrone Bio Innovations shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This table compares Marrone Bio Innovations and Ciner Resources’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Marrone Bio Innovations||-189.32%||N/A||-59.64%|
This is a breakdown of recent recommendations for Marrone Bio Innovations and Ciner Resources, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Marrone Bio Innovations||0||2||1||0||2.33|
Marrone Bio Innovations presently has a consensus target price of $1.75, indicating a potential upside of 57.66%. Ciner Resources has a consensus target price of $28.75, indicating a potential upside of 20.24%. Given Marrone Bio Innovations’ higher probable upside, equities research analysts clearly believe Marrone Bio Innovations is more favorable than Ciner Resources.
Ciner Resources pays an annual dividend of $2.27 per share and has a dividend yield of 9.5%. Marrone Bio Innovations does not pay a dividend. Ciner Resources pays out 114.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Ciner Resources beats Marrone Bio Innovations on 7 of the 12 factors compared between the two stocks.
Marrone Bio Innovations Company Profile
Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.
Ciner Resources Company Profile
Ciner Resources LP, through its subsidiary, Ciner Wyoming LLC (Ciner Wyoming), produces soda ash and serves a global market from its facility in the Green River Basin of Wyoming. The Company processes trona ore into soda ash, a raw material in flat glass, container glass, detergents, chemicals, paper and other consumer and industrial products. As of December 31, 2016, its Green River Basin surface operations were situated on approximately 880 acres in Wyoming, and the Company’s mining operations included approximately 23,500 acres of leased and licensed subsurface mining area. The Company’s mining leases and license are located in two mining beds, designated by the United States Geological Survey as beds 24 and 25, at depths of 800 to 1100 feet, respectively, below the surface. The Company uses a continuous mining technique to mine trona and roof bolt the ceiling simultaneously. The Company’s soda ash is shipped by rail or truck from its Green River Basin operations.
Receive News & Ratings for Marrone Bio Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.